124 related articles for article (PubMed ID: 33614286)
1. Prognostic implications of cell division cycle protein 45 expression in hepatocellular carcinoma.
Yang C; Xie S; Wu Y; Ru G; He X; Pan HY; Wang S; Tong X
PeerJ; 2021; 9():e10824. PubMed ID: 33614286
[TBL] [Abstract][Full Text] [Related]
2. Expression of Cell Division Cycle Protein 45 in Tissue Microarrays and the CDC45 Gene by Bioinformatics Analysis in Human Hepatocellular Carcinoma and Patient Outcomes.
Lu HP; Du XF; Li JD; Huang SN; He RQ; Wu HY; Li MF; Wu WZ; Chen JT; Mo WJ; Chen G
Med Sci Monit; 2021 Feb; 27():e928800. PubMed ID: 33622998
[TBL] [Abstract][Full Text] [Related]
3. Nine hub genes related to the prognosis of HBV-positive hepatocellular carcinoma identified by protein interaction analysis.
Xie W; Wang B; Wang X; Hou D; Su H; Huang H
Ann Transl Med; 2020 Apr; 8(7):478. PubMed ID: 32395522
[TBL] [Abstract][Full Text] [Related]
4. A novel prognostic biomarker SPC24 up-regulated in hepatocellular carcinoma.
Zhu P; Jin J; Liao Y; Li J; Yu XZ; Liao W; He S
Oncotarget; 2015 Dec; 6(38):41383-97. PubMed ID: 26515591
[TBL] [Abstract][Full Text] [Related]
5. Validation of CDC45 as a novel biomarker for diagnosis and prognosis of gastric cancer.
Wu L; Gao G; Mi H; Luo Z; Wang Z; Liu Y; Wu L; Long H; Shen Y
PeerJ; 2024; 12():e17130. PubMed ID: 38515458
[TBL] [Abstract][Full Text] [Related]
6. Down-regulation of the tumour suppressor κ-opioid receptor predicts poor prognosis in hepatocellular carcinoma patients.
Chen D; Chen Y; Yan Y; Pan J; Xing W; Li Q; Zeng W
BMC Cancer; 2017 Aug; 17(1):553. PubMed ID: 28821282
[TBL] [Abstract][Full Text] [Related]
7. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.
Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD
World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703
[TBL] [Abstract][Full Text] [Related]
8. Transcriptional analysis of the expression, prognostic value and immune infiltration activities of the COMMD protein family in hepatocellular carcinoma.
Wang X; He S; Zheng X; Huang S; Chen H; Chen H; Luo W; Guo Z; He X; Zhao Q
BMC Cancer; 2021 Sep; 21(1):1001. PubMed ID: 34493238
[TBL] [Abstract][Full Text] [Related]
9. Expression and prognosis of CDC45 in cervical cancer based on the GEO database.
He Z; Wang X; Yang Z; Jiang Y; Li L; Wang X; Song Z; Wang X; Wan J; Jiang S; Zhang N; Cui R
PeerJ; 2021; 9():e12114. PubMed ID: 34557356
[TBL] [Abstract][Full Text] [Related]
10. Low expression of organic anion-transporting polypeptide 1B3 predicts a poor prognosis in hepatocellular carcinoma.
Chen S; Li K; Jiang J; Wang X; Chai Y; Zhang C; Deng Q; Shuai L; Feng K; Ma K; Zhang L
World J Surg Oncol; 2020 Jun; 18(1):127. PubMed ID: 32534581
[TBL] [Abstract][Full Text] [Related]
11. [CDK1, CCNB1 and NDC80 are associated with prognosis and progression of hepatitis B virus-associated hepatocellular carcinoma: a bioinformatic analysis].
Li Y; Wu D; Wei C; Yang X; Zhou S
Nan Fang Yi Ke Da Xue Xue Bao; 2021 Oct; 41(10):1509-1518. PubMed ID: 34755666
[TBL] [Abstract][Full Text] [Related]
12. Low
Cheng Y; Xing SG; Jia WD; Huang M; Bian NN
Onco Targets Ther; 2017; 10():47-54. PubMed ID: 28031722
[TBL] [Abstract][Full Text] [Related]
13. MCM10 Acts as a Potential Prognostic Biomarker and Promotes Cell Proliferation in Hepatocellular Carcinoma: Integrated Bioinformatics Analysis and Experimental Validation.
Wan W; Shen Y; Li Q
Cancer Manag Res; 2020; 12():9609-9619. PubMed ID: 33116820
[TBL] [Abstract][Full Text] [Related]
14. Bioinformatics Analysis of Candidate Genes and Pathways Related to Hepatocellular Carcinoma in China: A Study Based on Public Databases.
Zhang P; Feng J; Wu X; Chu W; Zhang Y; Li P
Pathol Oncol Res; 2021; 27():588532. PubMed ID: 34257537
[No Abstract] [Full Text] [Related]
15. The expression of beclin-1, an autophagic gene, in hepatocellular carcinoma associated with clinical pathological and prognostic significance.
Qiu DM; Wang GL; Chen L; Xu YY; He S; Cao XL; Qin J; Zhou JM; Zhang YX; E Q
BMC Cancer; 2014 May; 14():327. PubMed ID: 24885292
[TBL] [Abstract][Full Text] [Related]
16. Microarray Data Mining and Preliminary Bioinformatics Analysis of Hepatitis D Virus-Associated Hepatocellular Carcinoma.
Yu Z; Ma X; Zhang W; Chang X; An L; Niu M; Chen Y; Sun C; Yang Y
Biomed Res Int; 2021; 2021():1093702. PubMed ID: 33564675
[TBL] [Abstract][Full Text] [Related]
17. Cell division cycle associated 8: A novel diagnostic and prognostic biomarker for hepatocellular carcinoma.
Cui XH; Peng QJ; Li RZ; Lyu XJ; Zhu CF; Qin XH
J Cell Mol Med; 2021 Dec; 25(24):11097-11112. PubMed ID: 34741389
[TBL] [Abstract][Full Text] [Related]
18. Phosphorylation of PED/PEA-15 at Ser116 and phosphorylation of p27 at Thr187 indicates a poor prognosis in hepatocellular carcinoma.
Wu Y; Li X; Chen M; Liu Z; Zhang X; Zheng S; Xu X
Oncol Lett; 2021 Mar; 21(3):177. PubMed ID: 33574916
[TBL] [Abstract][Full Text] [Related]
19. Upregulation of Stress-Induced Protein Kinase CK1 Delta is associated with a Poor Prognosis for patients with Hepatocellular Carcinoma.
Zhang H; Qiu C; Zeng H; Zhu W; Lyu W; Lao X
Genet Test Mol Biomarkers; 2021 Jul; 25(7):504-514. PubMed ID: 34280005
[No Abstract] [Full Text] [Related]
20. Increased expression of osteopontin indicates poor prognosis in hepatocellular carcinoma.
Wang H; Guo D; Li J; Wei B; Zheng H
Int J Clin Exp Pathol; 2018; 11(12):5916-5922. PubMed ID: 31949679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
